Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

MP201 Prodrug Synthesis and Supply

Open
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Blue Bell, PA, USA

Set-Aside

NONE

Documents

This scope was carved out of HT9426-27-NOI-049825.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Notice of Intent (NOI) to Sole Source proprietary prodrug MP201 to ISB for testing Acute Stress Reactions (ASRs)

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Due in 46 days

Read the full solicitation package

This scope is part of a larger contract. Its documents live on the prime.

  • 1 document on the prime contractFrom Notice of Intent (NOI) to Sole Source proprietary prodrug MP201 to ISB for testing Acute Stress Reactions (ASRs)
Read the prime's documents

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Synthesizes and supplies two batches of the proprietary prodrug MP201 for prime contractors on Defense Health Agency (DHA) projects. Produces two freshly made lots of MP201 and calibrates target dosages ranging from 8 to 80 mg/kg body weight for oral administration in mice. Provides quality control (QC) documentation and dosage background information. Delivers synthesized MP201 prodrug and associated QC/dosage documentation.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
CHARCOAL, ACTIVATED, SUS
Solicitation # SPE2DP-27-T-0383
Solicitation SPE2DP-27-T-0383 is a small business set-aside procurement for the Department of Defense, specifically the Medical Supply Chain Pharm FSA, for the supply of activated charcoal suspension. The requirement is for four bottles, each containing 50 grams in a 240 ml volume (NSN 6505-01-282-880), with a required delivery date of November 17, 2026. Delivery is specified as FOB Destination to a shipping address in Poland, with a required delivery timeline of 20 days after order. The material must be stored between 20 and 25 degrees Celsius and must have a shelf life of 36 months, with no more than five months elapsed from the date of manufacture to the date of delivery. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and special packaging instructions MPPWN00001. Marking must follow Medical Marking Standard No. 1, and labels must include the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and receiving reports. The contract incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, cybersecurity safeguarding, and hazardous material identification. Inspection and acceptance will be performed at the destination per FAR 52.246-2.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 1 hour ago

DEADLINE

in 7 days
View Details

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 541715
New
Federal
Notice of Intent (NOI) to Sole Source proprietary prodrug MP201 to ISB for testing Acute Stress Reactions (ASRs)
Solicitation # HT9426-27-NOI-049825
The Defense Health Agency, on behalf of the Walter Reed Army Institute of Research, has issued a Notice of Intent to sole source the procurement of the proprietary prodrug MP201 to the Integrative Systems Biology (ISB) Branch. The primary objective is to support the testing of Acute Stress Reactions (ASRs). The scope of work requires the contractor to supply two freshly made batches of MP201 synthesized for oral administration in mice, with target dosages ranging approximately from 8 to 80 mg/kg body weight. In addition to the physical product, the contractor must provide quality control documentation, dosage background information, and technical support to assist the ISB research team in preparing related reports and manuscripts. This action is identified by solicitation number HT9426-27-NOI-049825 and is categorized under NAICS code 541715. As this is a Notice of Intent and not a request for competitive proposals, no formal solicitation document or pricing data is currently available. Interested parties must submit capability statements in writing via PDF, MS Word, or Excel to Herbert Keen or Lance Nowell by 2:00 p.m. Eastern Time on December 31, 2026. All submissions must be unclassified, as the agency has explicitly stated that classified material should not be submitted.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 6 hours ago

DEADLINE

in about 2 months
View Details
NAICS: 561910
New
Federal
Instrument Sterilization Services for Fort Drum, NY
Solicitation # HT001427QE009
The Defense Health Agency is seeking a contractor to provide off-site instrument sterilization services for the Guthrie Army Health Clinic at Fort Drum, New York, supporting primary care, orthopedics, and dermatology clinics. The scope of work includes the manual, mechanical, or combined cleaning, lubrication, packaging, and sterilization of approximately 140 instrument sets and 135 individual instruments per month, with instrument sharpening provided on an as-needed basis. To ensure operational continuity and mitigate weather-related disruptions, the contractor must be located within a 30-mile radius of Fort Drum. The period of performance spans from December 1, 2026, through November 30, 2031, consisting of a base year and subsequent option years. Contractors must be accredited by The Joint Commission and comply with CDC and ANSI/AAMI ST79 guidelines. Strict packaging and marking requirements apply, including the use of brown indelible markings for identification, clinic-specific color coding, and the use of a clean shipping container provided by the clinic. Award will be based on the Lowest Price Technically Acceptable (LPTA) process, with a 10 percent price evaluation preference for HUBZone small business concerns. All payment requests and receiving reports must be processed through the Wide Area Workflow system.
Packaging and Labeling Services

POSTED

about 6 hours ago

DEADLINE

in 3 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking proposals for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This medical countermeasure must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent systemic infections in combat scenarios. The project aims to advance the technology from a preferred starting point of Technology Readiness Level 5 to TRL 8, culminating in a product that has received U.S. Food and Drug Administration approval or clearance. The scope of work includes preclinical testing, human clinical trials, and the submission of regulatory packages such as New Drug Applications or Premarket Approval Applications. This effort is being conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning it does not follow standard FAR-based procurement processes. The government prefers a Firm Fixed Price agreement, though Cost Plus Fixed Fee is acceptable. The estimated period of performance is 48 months, divided into prototype demonstration, clinical studies and regulatory submissions, and final FDA review. To be eligible, offerors must be registered in the System for Award Management and demonstrate participation by nontraditional defense contractors or non-profit research institutes, or provide a significant cost share. Proposals are due by November 20, 2026, and will be evaluated based on the proposer's demonstrated ability to successfully develop and deliver the prototype.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

3 days ago

DEADLINE

in 4 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS